10-Q Filing

Xenetic Biosciences, Inc. CIK: 1534525 Q1 2019

Filing Information

Form Type	10-Q
Accession Number	`0001683168-19-001471`
Period End Date	20190331
Filing Date	20190513
Fiscal Year	2019
Fiscal Period	Q1
XBRL Instance	xbio-20190331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 58 Income Statement 22 Cash Flow Statement 40 Stockholders Equity 20

Balance Sheet 58 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	45.45M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	45.45M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	10.77M	shares	Point-in-time
Cash	`Cash`	$2.02M	USD	Point-in-time
Cash	`Cash`	$571.61K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	9.73M	shares	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalents`	$66.51K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	10.44M	shares	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalents`	$66.51K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	9.40M	shares	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$555.86K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$1.12M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.19M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$3.20M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.96K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$3.50K	USD	Point-in-time
Goodwill	`Goodwill`	$3.28M	USD	Point-in-time
Goodwill	`Goodwill`	$3.28M	USD	Point-in-time
Indefinite-lived intangible assets	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$9.24M	USD	Point-in-time
Indefinite-lived intangible assets	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$9.24M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$724.79K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$705.66K	USD	Point-in-time
Total assets	`Assets`	$16.46M	USD	Point-in-time
Total assets	`Assets`	$14.43M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.04M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$934.15K	USD	Point-in-time
Accrued expenses and other current liabilities	`OtherLiabilitiesCurrent`	$665.64K	USD	Point-in-time
Accrued expenses and other current liabilities	`OtherLiabilitiesCurrent`	$965.74K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.60M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.01M	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilitiesNoncurrent`	$2.92M	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilitiesNoncurrent`	$2.92M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$13.12K	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	-	USD	Point-in-time
Total liabilities	`Liabilities`	$4.94M	USD	Point-in-time
Total liabilities	`Liabilities`	$4.52M	USD	Point-in-time
Commitments (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value; 45,454,546 shares authorized as of March 31, 2019 and December 31, 2018; 10,767,774 and 9,727,774 shares issued as of March 31, 2019 and December 31, 2018, respectively; 10,443,889 and 9,403,889 shares outstanding as of March 31, 2019 and December 31, 2018, respectively	`CommonStockValue`	$10.77K	USD	Point-in-time
Common stock, $0.001 par value; 45,454,546 shares authorized as of March 31, 2019 and December 31, 2018; 10,767,774 and 9,727,774 shares issued as of March 31, 2019 and December 31, 2018, respectively; 10,443,889 and 9,403,889 shares outstanding as of March 31, 2019 and December 31, 2018, respectively	`CommonStockValue`	$9.73K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$168.16M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$171.09M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-154.56M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-153.23M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$253.73K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$253.73K	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$5.28M	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$5.28M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$9.91M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$11.52M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$12.89M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$14.30M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$14.43M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$16.46M	USD	Point-in-time

Income Statement 22 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$706.27K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$463.78K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.12M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$863.37K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.83M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.33M	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$5.40K	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-245.00	USD	1 Quarter
Interest income	`InterestIncomeExpenseNet`	$427.00	USD	1 Quarter
Interest income	`InterestIncomeExpenseNet`	$150.00	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-95.00	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$5.83K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.33M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.82M	USD	1 Quarter
Deemed dividend	`OtherPreferredStockDividendsAndAdjustments`	-	USD	1 Quarter
Deemed dividend	`OtherPreferredStockDividendsAndAdjustments`	$3.88M	USD	1 Quarter
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-5.21M	USD	1 Quarter
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.82M	USD	1 Quarter
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.54	USD	1 Quarter
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.21	USD	1 Quarter
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	9.68M	shares	1 Quarter
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	8.72M	shares	1 Quarter

Cash Flow Statement 40 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-1.33M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.82M	USD	1 Quarter
Depreciation	`Depreciation`	$1.46K	USD	1 Quarter
Depreciation	`Depreciation`	$5.72K	USD	1 Quarter
Gain on sale of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	1 Quarter
Gain on sale of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$2.00K	USD	1 Quarter
Share-based expense	`ShareBasedCompensation`	$243.09K	USD	1 Quarter
Share-based expense	`ShareBasedCompensation`	$383.85K	USD	1 Quarter
Warrant-based income (expense) for services	`AdjustmentOfWarrantsGrantedForServices`	$-26.58K	USD	1 Quarter
Warrant-based income (expense) for services	`AdjustmentOfWarrantsGrantedForServices`	$4.92K	USD	1 Quarter
Vendor share-based expense	`VendorSharebasedPayments`	$17.43K	USD	1 Quarter
Vendor share-based expense	`VendorSharebasedPayments`	$17.43K	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$51.89K	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$536.70K	USD	1 Quarter
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$376.03K	USD	1 Quarter
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-204.31K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.25M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.67M	USD	1 Quarter
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	1 Quarter
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$2.00K	USD	1 Quarter
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	1 Quarter
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$2.00K	USD	1 Quarter
Net proceeds from issuance of common stock and warrants	`ProceedsFromIssuanceOrSaleOfEquity`	-	USD	1 Quarter
Net proceeds from issuance of common stock and warrants	`ProceedsFromIssuanceOrSaleOfEquity`	$2.70M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.70M	USD	1 Quarter
Net change in cash and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$1.45M	USD	1 Quarter
Net change in cash and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-1.67M	USD	1 Quarter
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.60M	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.93M	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$638.12K	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.08M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.60M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.93M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$638.12K	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.08M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$8.00	USD	1 Quarter
Cash paid for interest	`InterestPaidNet`	$671.00	USD	1 Quarter
Right of use asset acquired in exchange for lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	-	USD	1 Quarter
Right of use asset acquired in exchange for lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$43.33K	USD	1 Quarter

Stockholders Equity 20 line items

Line Item	Tag	Value	Unit	Period
Beginning balance, value	`StockholdersEquity`	$9.91M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$11.52M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$12.89M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$14.30M	USD	Point-in-time
Common stock awards to vendors	`StockIssuedDuringPeriodValueIssuedForServices`	$17.43K	USD	1 Quarter
Common stock awards to vendors	`StockIssuedDuringPeriodValueIssuedForServices`	$17.43K	USD	1 Quarter
Warrant revaluation (income)	`AdjustmentsToAdditionalPaidInCapitalOther`	$-26.58K	USD	1 Quarter
Warrant revaluation (income)	`AdjustmentsToAdditionalPaidInCapitalOther`	$4.92K	USD	1 Quarter
Issuance of common stock and warrants in March 2019 registered direct offering, net of issuance costs, value	`StockIssuedDuringPeriodValueNewIssues`	$2.70M	USD	1 Quarter
Deemed dividend related to Series B Preferred Stock down round provision	`DeemedDividendRelatedToSeriesBPreferredStockDownRoundProvision`	$3.88M	USD	1 Quarter
Accretion of deemed dividend related to Series B Preferred Stock down round provision	`OtherPreferredStockDividendsAndAdjustments`	-	USD	1 Quarter
Accretion of deemed dividend related to Series B Preferred Stock down round provision	`OtherPreferredStockDividendsAndAdjustments`	$3.88M	USD	1 Quarter
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$383.85K	USD	1 Quarter
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$243.09K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.33M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.82M	USD	1 Quarter
Ending balance, value	`StockholdersEquity`	$9.91M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$11.52M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$12.89M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$14.30M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.